§ Federal grant opportunity · PAR-24-216
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration is accepting applications for Minor Use Minor Species Development of Drugs (R01). The deadline is January 29, 2027 and the published award range is $250K.
Key facts
- Funder
- Food and Drug Administration
- Application deadline
- January 29, 2027
- Award range
- $250K
- Eligibility
- • Faith-based or Community-based Organizations• Regional Organizations• Non-domestic (non-U.S.) Entities (Foreign Organizations)
- Geography
- United States
- Focus areas
- Agriculture, Consumer Protection, Food Security
- Opportunity number
- PAR-24-216
Program overview
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants. The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516. FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Food and Drug Administration.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before January 29, 2027, allowing time for registration and validation.
Related grant opportunities
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- Training and Employment Guidance Letter (02-26) for FY 2026 Community Project Funding/Congressionally Directed Spending
- Agriculture Innovation Center Grant Program
- Established Program to Stimulate Competitive Research (EPSCoR) Basic Research
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.